Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.0073 | 0.9 |